Documents connected to "AFib Stroke Prevention"

September 12, 2016

Celebrating a Year Without a Stroke: Tips for you to simply talk with your atrial fibrillation patients about stroke prevention

The risk of stroke from atrial fibrillation (AFib) is real, and can quickly change a patient's life. As you know, the scientific evidence confirms that oral anticoagulation is highly effective at reducing stroke risk. Yet, elderly patients are too often under-anticoagulted, owing in part to their lack of understanding about stroke risk and the value of anticoagulation. This tip sheet offers talking points to help health care professionals help their patients to better understand why anticoagulation is critical and how adherence will allow them to celebate more years without a stroke.
January 29, 2016

AFib Multiple Chronic Conditions Letter

Letter from the Afib Optimal Treatment Task Force commenting on the efforts of the Senate Finance Committee's working group on multiple chronic conditions (MCC) policy options white paper.  
January 26, 2016

MCC Working Group Comment Letter

The Alliance for Aging Research’s sent a comment letter concerning the Senate Finance Committees’ Multiple Chronic Conditions (MCC) Working Group’s…
November 13, 2015

AFib Healthy People 2020 Letter

The Alliance for Aging Research led AFib Optimal Treatment Task Force submitted a letter to the CDC commenting on the agency's Healthy People 2020 goals. The letter recommended: The CDC should add Afib as a modifiable risk factor for stroke The CDC address the under anticoagulation of older AFib patients as an emerging issue in heart disease and stroke
July 1, 2015

Letter to PCORI on Stakeholder Workshop on the Use of New Oral Anticoagulants

The AFib Optimal Treatment Task Force sent this letter to the Patient-Centered Outcomes Research Institute (PCORI) regarding its June 9,…
March 27, 2015

FY16 AFib Appropriations Sign-On Letter

The Alliance for Aging Research signed onto a letter requesting the National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), and other relevant NIH agencies, institutes, and offices provide technical assistance and otherwise support an effort to improve prevention of AFib-related stroke in older persons.
March 25, 2015

Call to Action to All Stakeholders Managing Elderly AFib Patients

On October 16, 2014 the Alliance for Aging Research convened a symposium to discuss those factors leading to the undertreatment of elderly AFib patients and to identify gaps in current clinical practice, outreach, education,  research, and policy. Read the full whitepaper to see the complete set of recommendations.
January 1, 2015

Atrial Fibrillation Survey Report–Insights and Analysis

A survey of more than 500 adults with atrial fibrillation age 65 and over, explored first diagnosis, referrals, their treatment decision process, anticoagulant use, medication switching, bleeding complications, and more.
June 9, 2014

Stroke Prevention in Atrial Fibrillation: A pocket guide to current guidelines and recommendations

Atrial fibrillation (AFib) affects around 5% of patients age 65 and older and 10% of patients age 80 or older.  AFib…
February 1, 2013

The Silver Book: Atrial Fibrillation Fact Sheet

Atrial fibrillation impacts between 2.7 and 6.1 million adults and can lead to stroke, heart failure, dementia, disability, and death.
December 1, 2012

Assessing Stroke and Bleeding Risk in Atrial Fibrillation–Consensus Statement Executive Summary

This executive summary shares the critical conclusions from the expert consensus statement that makes important recommendations on the use of…
September 28, 2012

AHRQ Submitted Comments on Key Questions for Stroke Prevention in Atrial Fibrillation–2012

September 28, 2012 Agency for Health Research and Quality Effective Health Care Program Scientific Resource Center, Oregon EPC…
September 4, 2012

PQRS Submitted Comments on Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule

September 4, 2012 Marilyn Tavenner Acting Administrator  Centers for Medicare & Medicaid Services Department of Health and Human Services Attn: CMS-1590-P P.O. Box 8013 Baltimore, MD 21244-8013  RE: Comments on Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule Dear Administrator Tavenner: Because of the growing impact atrial fibrillation (AFib) is having on our aging population, the AFib Optimal Treatment Task Force, comprised of 12 leading organizations in the thrombosis space, formed in 2011 to raise awareness of the impact of the disease and to explore issues related to the process used by healthcare providers to assess both stroke and bleeding risk in making decisions about anticoagulation therapy for patients with AFib. We appreciate the opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule. Our comments on the proposed rule will be limited to a new measure #1525, Chronic Anticoagulation Therapy, which is under consideration by CMS for inclusion in the Physician Quality Reporting System (PQRS) for CY2013. Recent expert consensus led by the AFib Optimal Treatment Task Force supports the use of this measure but with an additional recommendation to encourage routine and proper bleeding risk assessment. We urge you to include a modified version of measure #1525 in the final rule that encourages a bleeding risk assessment in addition to a stroke risk assessment to ensure that Medicare beneficiaries with AFib are presented with all treatment options that may be available for them.
September 1, 2012

Atrial Fibrillation Patient Survey Highlights

This survey of more than 500 atrial fibrillation patients, ages 65+ from across the nation, revelead diagnosis and treatment experiences,…
September 1, 2012

Atrial Fibrillation Patient Survey Full Results

This survey of more than 500 atrial fibrillation patients, ages 65+ from across the nation, revelead diagnosis and treatment experiences,…
July 1, 2012

Assessing Stroke and Bleeding Risk in Atrial Fibrillation – Consensus Statement

This expert consensus statement makes important recommendations on the use of stroke and bleeding risk tools, the decision to anticoagulate,…
June 1, 2012

Atrial Fibrillation Health Care Professional Survey – Full Results

A survey of more than 400 geriatricians, internists, and primary care physicians revealed a number of barriers to optimal AFib…
June 1, 2012

Atrial Fibrillation Health Care Professional Survey – Highlights

A survey of more than 400 geriatricians, internists, and primary care physicians revealed a number of barriers to optimal AFib…
March 5, 2012

PCORI Submitted Comments on National Priorities for Research and Research Agenda

March 15, 2012 Joe V. Selby, M.D., M.P.H. Executive Director Patient Centered Outcomes Research Institute 1701 Pennsylvania Ave, NW Suite 300 Washington, D.C. 20006 RE: Comments on PCORI National Priorities for Research and Research Agenda Dear Dr. Selby: The groups below comprise a task force of leading organizations in the thrombosis space that are exploring issues related to optimal stroke prevention in atrial fibrillation. Participants in this task force represent various audiences—from patients to health care providers—that are unified by the desire to improve the way in which stroke and bleeding risk are assessed in atrial fibrillation patients and ensure proper treatment of these patients. In our capacity as health care stakeholders, we support the Patient Centered Outcomes Research Institute’s (PCORI) mission to improve health care delivery and outcomes by producing and promoting high integrity, evidence-based information that comes from research guided by patients, caregivers and the health care community. As such we appreciate the opportunity to comment on PCORI’s national research priorities and research agenda.
October 4, 2011

AHRQ Submitted Comments on Key Questions for Stroke Prevention in Atrial Fibrillation

AHRQ Comments Home > Aging Topics > Atrial Fibrillation > AHRQ Comments October 14, 2011 Agency for Healthcare Research and Quality Effective Health Care Program Scientific Resource Center, Oregon EPC Mail Code: BICC 3181 S.W. Sam Jackson Park Road Portland, Oregon 97239-3098 RE: Comment on Key Questions for Stroke Prevention in Atrial Fibrillation Dear Sir or Madam: Thank you for the opportunity to comment on AHRQ’s key questions related to the Effective Health Care Program’s comparative effectiveness review of stroke prevention in atrial fibrillation. We believe this is an important time to review in light of the growing impact atrial fibrillation has on our aging population and the uncertainty that exists about the best way to treat older patients with the condition.
March 11, 2011

The Silver Book: Thrombosis

Each year around 75,000 Americans are diagnosed with AFib, 900,000 experience a VTE event, adn 800,000 have a stroke.  Some…
January 1, 2011

AFib Optimal Treatment Expert Roundtable–Effectively Assessing Stroke and Bleeding Risk in Anticoagulation Decision-Making (Briefing Book)

This roundtable explored the risk assessment tools and their limitations, discussed how the tools should be updated to overcome those…